Conio M, Cameron A J, Romero Y, Branch C D, Schleck C D, Burgart L J, Zinsmeister A R, Melton L J, Locke G R
Division of Gastroenterology and Hepatology, Mayo Foundation, Rochester, Minnesota 55901, USA.
Gut. 2001 Mar;48(3):304-9. doi: 10.1136/gut.48.3.304.
The incidence of oesophageal adenocarcinoma has increased greatly. Barrett's oesophagus is a known risk factor.
To identify changes in the incidence, prevalence, and outcome of Barrett's oesophagus in a defined population.
Residents of Olmsted County, Minnesota, with clinically diagnosed Barrett's oesophagus, or oesophageal or oesophagogastric junction adenocarcinoma.
Cases were identified using the Rochester Epidemiology Project medical records linkage system. Records were reviewed with follow up to 1 January 1998.
The incidence of clinically diagnosed Barrett's oesophagus (>3 cm) increased 28-fold from 0.37/100 000 person years in 1965-69 to 10.5/100 000 in 1995-97. Of note, gastroscopic examinations increased 22-fold in this same time period. The prevalence of diagnosed Barrett's oesophagus increased from 22.6 (95% confidence interval (CI) 11.7-33.6) per 100 000 in 1987 to 82.6/100 000 in 1998. The prevalence of short segment Barrett's oesophagus (<3 cm) in 1998 was 33.4/ 100 000. Patients with Barrett's oesophagus had shorter than expected survival but only one patient with Barrett's oesophagus died from adenocarcinoma. Only four of 64 adenocarcinomas occurred in patients with previously known Barrett's oesophagus.
The incidence and prevalence of clinically diagnosed Barrett's oesophagus have increased in parallel with the increased use of endoscopy. We infer that the true population prevalence of Barrett's oesophagus has not changed greatly, although the incidence of oesophageal adenocarcinoma increased 10-fold. Many adenocarcinomas occurred in patients without a previous diagnosis of Barrett's oesophagus, suggesting that many people with this condition remain undiagnosed in the community.
食管腺癌的发病率大幅上升。巴雷特食管是已知的危险因素。
确定特定人群中巴雷特食管的发病率、患病率及转归的变化。
明尼苏达州奥尔姆斯特德县临床诊断为巴雷特食管、食管或食管胃交界腺癌的居民。
利用罗切斯特流行病学项目医疗记录链接系统识别病例。对记录进行回顾,随访至1998年1月1日。
临床诊断的巴雷特食管(>3 cm)的发病率从1965 - 1969年的0.37/10万人口年增加了28倍,至1995 - 1997年达到10.5/10万。值得注意的是,同期胃镜检查增加了22倍。确诊的巴雷特食管的患病率从1987年的每10万人中22.6例(95%置信区间(CI)11.7 - 33.6)增至1998年的82.6/10万。1998年短节段巴雷特食管(<3 cm)的患病率为33.4/10万。巴雷特食管患者的生存期短于预期,但仅有1例巴雷特食管患者死于腺癌。64例腺癌中只有4例发生在先前已知患有巴雷特食管的患者中。
临床诊断的巴雷特食管的发病率和患病率与内镜检查使用的增加同步上升。我们推断,尽管食管腺癌的发病率增加了10倍,但巴雷特食管的实际人群患病率并未有太大变化。许多腺癌发生在先前未诊断为巴雷特食管的患者中,这表明社区中许多患有这种疾病的人仍未被诊断出来。